The thought of foot orthotic dosing continues to be getting increased attention lately. It is actually in line with the analogy of drugs or medication dosage. Everyone who may be taking a different drug or medicine for any medical condition have to theoretically taking an individual measure or quantity of that medicine. The same ought to be the case pertaining to foot orthoses. A different “dose” of foot orthoses should really be applied. All too often foot orthoses are generally used the identical dose of foot supports, particularly in clinical studies or research. An episode of the weekly podiatry live show, PodChatLive hammered out this problem. The hosts of that episode talked with Simon Spooner in an attempt to highlight some of the limitations of foot orthotics research in accordance with the idea. They discussed the way in which health professionals really should be viewing all results from research made in the framework of these limitations. They talked about as to what “perfect” foot orthoses research could possibly look like, the points we might need to ‘measure’ and also the evident discourse between the lab and the clinic. Most importantly they outlined what ‘dosing’ is, and just how it can help us resolve questions that are at present left unanswered.
Dr Simon Spooner graduated as a Podiatrist in 1991 graduating from the University of Brighton, as well as to his BSc in Podiatry, he had been awarded the Paul Shenton award for his research into callus. He then continued to accomplish his PhD in Podiatry from the University of Leicester in 1997, where he researched the reasons and therapy for inherited foot problems. Simon is now the Director of Podiatry at Peninsula Podiatry. His clinic expertise include sports medicine, foot orthotics, and children and adult foot and gait problems. In addition to his own clinical work, Simon has published a number of research articles on podiatric care and has delivered papers at both national and international meetings, and presented postgraduate education for many NHS Trusts.